Effects of Liraglutide on Glycemia, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Liraglutide injection; Drug: Insulin Glargine Sponsor: University of Palermo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2022 Category: Research Source Type: clinical trials
Effects of Liraglutide, Empagliflozin and Linagliptin on the Cognitive Function in T2DM Patients With Mild Cognitive Impairment: a Multicenter, Randomized, Parallel Controlled Clinical Trial
Conditions: Type 2 Diabetes Mellitus; Mild Cognitive Impairment Interventions: Drug: Liraglutide; Drug: Empagliflozin; Drug: Linagliptin Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Wuxi People's Hospital; The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2022 Category: Research Source Type: clinical trials
A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza ® in Healthy Chinese Subjects
Condition: Type 2 Diabetes Interventions: Drug: Liraglutide injection,RD12014; Drug: Liraglutide injection,Victoza Sponsor: Sunshine Lake Pharma Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2022 Category: Research Source Type: clinical trials
